References
- Argas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH, Meza-Cabrera I. Autoimmune thyroid disease (flajani-parry-graves-von basedow disease): Etiopathogenesis, clinical manifestations and diagnosis. In: Imam S, Ahmad S, editors. Thyroid Disorders. Cham: Springer; 2016.
- Yanachkova V, Kamenov Z. The relationship between thyroid dysfunction during pregnancy and gestational diabetes mellitus. Endokrynol Pol. 2021;72(3):226-31. https://doi.org/10.5603/EP.a2021.0016 PMid:33619713
- De Groot LJ, Larsen PR, Hennemann G. The Thyroid and its Diseases. 6th ed. United Kingdom: Churchill Livingstone; 1995
- Weetman A. Autoimmune thyroid disease. Endocrine. 2020;68(2):258-60. https://doi.org/10.1007/s12020-020-02188-6 PMid:320523689.
- Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of graves’ hyperthyroidism. Eur Thyroid J. 2018;7(4):167-86. http://doi.org/10.1159/000490384 PMid:302837357.
- McGrogan A, Seaman HE, Wright JW, de Vries CS. The incidence of autoimmune thyroid disease: A systematic review of the literature. Clin Endocrinol (Oxf). 2008;69(5):687-96. https://doi.org/10.1111/j.1365-2265.2008.03338.x PMid:18673466
- Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O’Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: A 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010;95(3):1095-104. http://doi.org/10.1210/jc.2009-1977 PMid:20097710
- Wahab F, Kearney E, Joseph S. The presence of thyroid peroxidase antibodies in Graves’ disease is predictive of disease duration and relapse rates. Endocr Abstr. 2013;31:P367. https://doi.org/10.1530/endoabs.31.P367
- Bartalena L, Piantanida E, Gallo D, Ippolito S, Tanda ML. Management of Graves’ hyperthyroidism: Present and future. Expert Rev Endocrinol Metab. 2022;17(2):153-66. http://doi.org/10.1080/17446651.2022.2052044 PMid:35287535
- Vargas-Uricoechea H. Molecular mechanisms in autoimmune thyroid disease. Cells. 2023;12(6):918. http://doi.org/10.3390/cells12060918 PMid:36980259
- Bossowski A, Stasiak-Barmuta A, Urban M. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves’ disease. Horm Res. 2005;64(4):189-97. https://doi.org/10.1159/000088875 PMid:16220002
- De Carvalho G, Perez C, Ward L. The clinical use of thyroid function tests. Arq Bras Endocrinol Metabol 2013;57(3):193-204. https://doi.org/10.1590/S0004-27302013000300005 PMid:23681265
- Fröhlich E, Wahl R. Thyroid autoimmunity: Role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521. http://doi.org/10.3389/fimmu.2017.00521 PMid:28536577
- Kaczur V, Vereb G, Molnár I, Krajczár G, Kiss E, Farid NR, et al. Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay. Clin Chem 1997;43(8 Pt 1):1392-6. PMid:9267319
- Xie LD, Gao Y, Li MR, Lu GZ, Guo XH. Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto’s thyroiditis with different thyroid functional status. Clin Exp Immunol. 2008;154(2):172-6. https://doi.org/10.1111/j.1365-2249.2008.03756.x PMid:18778360
- Caturegli P, Kuppers RC, Mariotti S, Burek CL, Pinchera A, Ladenson PW, et al. IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp Immunol 1994;98(3):464-9. https://doi.org/10.1111/j.1365-2249.1994.tb05514.x PMid:7994910
- Siriwardhane T, Krishna K, Ranganathan V, Jayaraman V, Wang T, Bei K, et al. Significance of anti-TPO as an early predictive marker in thyroid disease. Autoimmune Dis. 2019;2019:1684074. https://doi.org/10.1155/2019/1684074 PMid:31467701
- Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, et al. Increased remission rates after long-term methimazole therapy in patients with Graves’ disease: Results of a randomized clinical trial. Thyroid. 2019;29(9):1192-200. https://doi.org/10.1089/thy.2019.0180 PMid:31310160
- Alhubaish ES, Alibrahim NT, Mansour AA. The Clinical Implications of anti-thyroid peroxidase antibodies in Graves’ disease in basrah. Cureus. 2023;15(3):e36778. https://doi.org/10.7759/cureus.36778 PMid:37123800